Metabolic dysregulation has been implicated in the pathogenesis of many immune-related diseases such as autoimmune diseases(such as T1DM), allergies, and cancer. Recent research has highlighted the role of metabolic pathways in immune responses and immune-related diseases. Omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, provide a powerful tool to comprehensively profile molecular changes in biological systems.
These technologies allow for a systems-level view of the molecular changes occurring in cells and tissues during physiological and pathological states. In the context of immune-related diseases, omics technologies have helped identify specific metabolic pathways that are dysregulated in different diseases and have characterized the molecular networks involved. However, there is still a need for further research to fully leverage the power of omics technologies to better understand the metabolic processes in immune-related diseases and identify new therapeutic targets. By improving our understanding of the underlying molecular mechanisms, we may be able to develop more effective strategies for diagnosing and treating immune-related diseases.
The goal of this research topic is to apply omics technologies to investigate the metabolic processes involved in immune-related diseases. By characterizing the molecular changes that occur in immune cells and tissues during different disease states, we aim to gain a better understanding of the metabolic dysregulation that contributes to immune dysfunction and the pathogenesis of immune-related diseases. Specifically, we aim to identify novel metabolic pathways and interactions that are dysregulated in different immune-related diseases and to explore their functional significance in the context of immune cell activation and differentiation.
The ultimate goal is to identify new therapeutic targets for immune-related diseases that can be exploited to develop more effective treatments. By integrating omics data with other types of biological data, such as imaging and clinical data, we aim to develop a more comprehensive understanding of the molecular mechanisms underlying immune-related diseases. This research has the potential to improve our ability to diagnose, monitor, and treat immune-related diseases, ultimately improving the quality of life for patients affected by these conditions.
The scope of this research topic is to investigate the application of omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, to metabolic processes in immune-related diseases. Specifically, we invite contributions that cover the following sub-themes:
1.Omics technologies for profiling metabolic changes in immune-related diseases
2.Dysregulated metabolic pathways and networks in immune-related diseases
3.Functional significance of metabolic dysregulation in immune-related diseases
4.Therapeutic targeting of genetic and metabolic pathways for immune-related diseases
5.Integration of omics data with other biological data to better understand the significance of metabolism in immune-related diseases
We are interested in receiving original research articles, reviews, and perspectives on this topic. We encourage contributions from researchers in diverse fields, including immunology, genetics, metabolism, systems biology, and bioinformatics. The manuscripts should provide insights into the metabolic regulation of immune responses and the pathogenesis of immune-related diseases, and highlight the potential of omics technologies for identifying metabolic related therapeutic targets.
Metabolic dysregulation has been implicated in the pathogenesis of many immune-related diseases such as autoimmune diseases(such as T1DM), allergies, and cancer. Recent research has highlighted the role of metabolic pathways in immune responses and immune-related diseases. Omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, provide a powerful tool to comprehensively profile molecular changes in biological systems.
These technologies allow for a systems-level view of the molecular changes occurring in cells and tissues during physiological and pathological states. In the context of immune-related diseases, omics technologies have helped identify specific metabolic pathways that are dysregulated in different diseases and have characterized the molecular networks involved. However, there is still a need for further research to fully leverage the power of omics technologies to better understand the metabolic processes in immune-related diseases and identify new therapeutic targets. By improving our understanding of the underlying molecular mechanisms, we may be able to develop more effective strategies for diagnosing and treating immune-related diseases.
The goal of this research topic is to apply omics technologies to investigate the metabolic processes involved in immune-related diseases. By characterizing the molecular changes that occur in immune cells and tissues during different disease states, we aim to gain a better understanding of the metabolic dysregulation that contributes to immune dysfunction and the pathogenesis of immune-related diseases. Specifically, we aim to identify novel metabolic pathways and interactions that are dysregulated in different immune-related diseases and to explore their functional significance in the context of immune cell activation and differentiation.
The ultimate goal is to identify new therapeutic targets for immune-related diseases that can be exploited to develop more effective treatments. By integrating omics data with other types of biological data, such as imaging and clinical data, we aim to develop a more comprehensive understanding of the molecular mechanisms underlying immune-related diseases. This research has the potential to improve our ability to diagnose, monitor, and treat immune-related diseases, ultimately improving the quality of life for patients affected by these conditions.
The scope of this research topic is to investigate the application of omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, to metabolic processes in immune-related diseases. Specifically, we invite contributions that cover the following sub-themes:
1.Omics technologies for profiling metabolic changes in immune-related diseases
2.Dysregulated metabolic pathways and networks in immune-related diseases
3.Functional significance of metabolic dysregulation in immune-related diseases
4.Therapeutic targeting of genetic and metabolic pathways for immune-related diseases
5.Integration of omics data with other biological data to better understand the significance of metabolism in immune-related diseases
We are interested in receiving original research articles, reviews, and perspectives on this topic. We encourage contributions from researchers in diverse fields, including immunology, genetics, metabolism, systems biology, and bioinformatics. The manuscripts should provide insights into the metabolic regulation of immune responses and the pathogenesis of immune-related diseases, and highlight the potential of omics technologies for identifying metabolic related therapeutic targets.
